Cognitive Dysfunction in Multiple Sclerosis: Educational Level as a Protective Factor.
RRMS
SPMS
cognitive dysfunction
educational level
multiple sclerosis
protective factor
Journal
Neurology international
ISSN: 2035-8385
Titre abrégé: Neurol Int
Pays: Switzerland
ID NLM: 101551564
Informations de publication
Date de publication:
22 Jul 2021
22 Jul 2021
Historique:
received:
19
05
2021
revised:
02
07
2021
accepted:
14
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Most people with MS experience cognitive deficits especially in attention, memory, information processing, and executive functions, negatively impacting on their quality of life. Cognitive variables of short-term memory, logical memory, and verbal fluency in 65 patients with multiple sclerosis (MS) were analysed in conjunction with sociodemographic variables such as sex, age, and educational level that might influence disease progression. We found that psychoeducational variables exerted a significant effect on the cognitive status of patients with MS. Thus, when considering sex, age, educational level, and type of MS (SPMS or RRMS), tests for between-subject effects revealed statistically significant differences in all three cognitive variables. In addition, we found that the type of MS and time since onset also generated significant cognitive differences. Our study shows that educational achievement or level is a protective factor against the disease, acting as a source of intellectual enrichment that promotes cognitive reserve in patients with MS. Further longitudinal studies assessing disease progression and prognosis in patients with MS would be useful in order to determine the specific importance of these variables in such patients and in strategies that could enhance their performance in neuropsychological assessment tasks.
Identifiants
pubmed: 34449709
pii: neurolint13030034
doi: 10.3390/neurolint13030034
pmc: PMC8395911
doi:
Types de publication
Journal Article
Langues
eng
Pagination
335-342Références
Mult Scler. 2020 Nov;26(13):1740-1751
pubmed: 31603042
Clin Rehabil. 2020 Feb;34(2):229-241
pubmed: 31769299
Scand J Psychol. 2008 Oct;49(5):479-85
pubmed: 18452499
Neurol Clin. 1987 Nov;5(4):585-600
pubmed: 3323878
Brain Sci. 2021 Mar 09;11(3):
pubmed: 33803287
Rev Neurol. 2009 Oct 1-15;49(7):343-8
pubmed: 19774527
Mult Scler. 2012 Jun;18(6):891-8
pubmed: 22190573
Mult Scler J Exp Transl Clin. 2019 Dec 11;5(4):2055217319894365
pubmed: 31853370
Neuropsychologia. 1998 Apr;36(4):295-304
pubmed: 9665640
Neurology. 2018 Feb 6;90(6):278-288
pubmed: 29343470
Mult Scler. 2000 Aug;6(4):241-54
pubmed: 10962545
Mult Scler Relat Disord. 2018 May;22:41-48
pubmed: 29554549
J Clin Neurol. 2018 Jul;14(3):387-392
pubmed: 29971979
Neurologia. 2004 May;19(4):153-9
pubmed: 15131734
Neurologia. 2014 Apr;29(3):139-45
pubmed: 23796761
Ann Neurol. 1983 Mar;13(3):227-31
pubmed: 6847134
Neuropsychol Rehabil. 2019 Dec;29(10):1543-1568
pubmed: 29498324
J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):38-43
pubmed: 21746743
Int J Psychol. 2019 Dec;54(6):705-711
pubmed: 30206941
Rev Neurol. 2005 Sep 1-15;41(5):257-62
pubmed: 16138280
Int J MS Care. 2017 Jul-Aug;19(4):165-171
pubmed: 28835740
Mult Scler. 2018 Jan;24(1):75-79
pubmed: 29307290
Mult Scler. 2012 Oct;18(10):1472-9
pubmed: 22383227
Neurology. 1989 Feb;39(2 Pt 1):161-6
pubmed: 2915783
J Clin Exp Neuropsychol. 2000 Dec;22(6):865-73
pubmed: 11320441
Brain Sci. 2021 Apr 16;11(4):
pubmed: 33923390